• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Thrombocytopenia and Thromboses in Myocardial Infarction Associated with Eptifibatide-Dependent Activating Antiplatelet Antibodies.

作者信息

Puram Rishi V, Erdil Rachel M, Weber Brittany N, Knelson Erik H, Van Beuningen Anne M, Wallwork Rachel, Gilyard Shenise N, Curtis Brian R, Ranganathan Rajesh, Leaf Rebecca K, Malhotra Rajeev

机构信息

Department of Medicine, Pathways Service, Massachusetts General Hospital, Boston, Massachusetts, United States.

Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States.

出版信息

Thromb Haemost. 2020 Jul;120(7):1137-1141. doi: 10.1055/s-0040-1712458. Epub 2020 May 29.

DOI:10.1055/s-0040-1712458
PMID:32483771
Abstract
摘要

相似文献

1
Thrombocytopenia and Thromboses in Myocardial Infarction Associated with Eptifibatide-Dependent Activating Antiplatelet Antibodies.依替巴肽依赖性激活抗血小板抗体相关心肌梗死中的血小板减少症和血栓形成
Thromb Haemost. 2020 Jul;120(7):1137-1141. doi: 10.1055/s-0040-1712458. Epub 2020 May 29.
2
Assessment of Ticagrelor Versus Clopidogrel Treatment in Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.替格瑞洛与氯吡格雷治疗ST段抬高型心肌梗死患者直接经皮冠状动脉介入治疗的疗效评估
J Cardiovasc Pharmacol. 2016 Aug;68(2):115-20. doi: 10.1097/FJC.0000000000000390.
3
Acute profound thrombocytopenia with second exposure to eptifibatide associated with a strong antibody reaction.再次使用依替巴肽后出现急性严重血小板减少症，并伴有强烈的抗体反应。
Platelets. 2009 Feb;20(1):64-7. doi: 10.1080/09537100802592676.
4
Eptifibatide-Induced Profound Thrombocytopenia After Percutaneous Intervention for Acute Coronary Syndrome: A Challenging Clinical Scenario.急性冠状动脉综合征经皮介入治疗后依替巴肽诱发的严重血小板减少症：一个具有挑战性的临床病例
Methodist Debakey Cardiovasc J. 2017 Oct-Dec;13(4):248-252. doi: 10.14797/mdcj-13-4-248.
5
Routine Glycoprotein IIb/IIIa Inhibitor Therapy in ST-Segment Elevation Myocardial Infarction: A Meta-analysis.常规糖蛋白 IIb/IIIa 抑制剂治疗 ST 段抬高型心肌梗死：一项荟萃分析。
Can J Cardiol. 2019 Nov;35(11):1576-1588. doi: 10.1016/j.cjca.2019.05.003. Epub 2019 May 7.
6
Left main stent thrombosis complicated by eptifibatide-induced acute thrombocytopenia.左主干支架内血栓形成并伴有依替巴肽诱导的急性血小板减少症。
Tex Heart Inst J. 2011;38(2):174-8.
7
Eptifibatide provides additional platelet inhibition in non-ST-elevation myocardial infarction patients already treated with aspirin and clopidogrel. Results of the platelet activity extinction in non-Q-wave myocardial infarction with aspirin, clopidogrel, and eptifibatide (PEACE) study.依替巴肽在已接受阿司匹林和氯吡格雷治疗的非ST段抬高型心肌梗死患者中可提供额外的血小板抑制作用。阿司匹林、氯吡格雷和依替巴肽用于非Q波心肌梗死患者血小板活性消除的研究（PEACE研究）结果。
J Am Coll Cardiol. 2004 Jan 21;43(2):162-8. doi: 10.1016/j.jacc.2003.08.033.
8
Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis.替格瑞洛或普拉格雷与氯吡格雷三联抗血小板治疗联合糖蛋白 IIb/IIIa 抑制剂用于接受 PCI 的 STEMI 患者：一项荟萃分析。
BMC Cardiovasc Disord. 2020 Mar 12;20(1):130. doi: 10.1186/s12872-020-01403-6.
9
Primary and secondary safety endpoints from IMPACT II. Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis.
Am J Cardiol. 1997 Aug 18;80(4A):29B-33B. doi: 10.1016/s0002-9149(97)00574-2.
10
Antiplatelet antibodies in childhood idiopathic thrombocytopenic purpura.儿童特发性血小板减少性紫癜中的抗血小板抗体
Am J Hematol. 1996 Apr;51(4):328. doi: 10.1002/(SICI)1096-8652(199604)51:4<328::AID-AJH14>3.0.CO;2-A.

引用本文的文献

1
Critical Analysis of Thrombocytopenia Associated With Glycoprotein IIb/IIIa Inhibitors and Potential Role of Zalunfiban, a Novel Small Molecule Glycoprotein Inhibitor, in Understanding the Mechanism(s).抗血小板药物致血小板减少症的分析及新型小分子糖蛋白Ⅱb/Ⅲa 抑制剂——扎鲁司亭的作用机制研究
J Am Heart Assoc. 2023 Dec 19;12(24):e031855. doi: 10.1161/JAHA.123.031855. Epub 2023 Dec 8.